Predicting response to M-VAC neoadjuvant chemotherapy for bladder cancers through genomewide gene expression profiling

被引：0
|
作者：
Takata, R
Katagiri, T
Kanehira, M
Tsunoda, T
Shuin, T
Miki, T
Namiki, M
Kohri, K
Matsushita, Y
Fujioka, T
Nakamura, Y
机构：
来源：
JOURNAL OF UROLOGY | 2006年 / 175卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)33205-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
980
引用
收藏
页码：316 / 316
页数：1
相关论文
共 50 条
  • [1] Predicting response of bladder cancers to gemcitabine and carboplatin neoadjuvant chemotherapy through genome-wide gene expression profiling
    Kato, Yoichiro
    Zembutsu, Hitoshi
    Takata, Ryo
    Miya, Fuyuki
    Tsunoda, Tatsuhiko
    Obara, Wataru
    Fujioka, Tomoaki
    Nakamura, Yusuke
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (01) : 47 - 56
  • [2] Study of the Prediction System for Clinical Response to M-VAC Neoadjuvant Chemotherapy for Bladder Cancer
    Takata, R.
    Obara, W.
    Fujioka, T.
    AKTUELLE UROLOGIE, 2010, 41 : S41 - S45
  • [3] Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling
    Takata, R
    Katagiri, T
    Kanehira, M
    Tsunoda, T
    Shuin, T
    Miki, T
    Namiki, M
    Kohri, K
    Matsushita, Y
    Fujioka, T
    Nakamura, Y
    CLINICAL CANCER RESEARCH, 2005, 11 (07) : 2625 - 2636
  • [4] Study of the Prediction System for Clinical Response to M-VAC Neoadjuvant Chemotherapy for Bladder Cancer Editorial Comment
    Montie, James E.
    JOURNAL OF UROLOGY, 2010, 184 (06): : 2277 - 2278
  • [5] Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapy
    Takata, Ryo
    Katagiri, Toyomasa
    Kanehira, Mitsugu
    Shuin, Taro
    Miki, Tsuneharu
    Namiki, Mikio
    Kohri, Kenjiro
    Tsunoda, Tatsuhiko
    Fujioka, Tomoaki
    Nakamura, Yusuke
    CANCER SCIENCE, 2007, 98 (01) : 113 - 117
  • [6] Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profiling
    Zembutsu, Hitoshi
    Suzuki, Yasuyo
    Sasaki, Aya
    Tsunoda, Tatsuhiko
    Okazaki, Minoru
    Yoshimoto, Masataka
    Hasegawa, Tadashi
    Hirata, Koichi
    Nakamura, Yusuke
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (02) : 361 - 370
  • [7] M-VAC CHEMOTHERAPY AND SURGERY FOR ADVANCED BLADDER-CARCINOMA
    HERR, HW
    YAGODA, A
    STERNBERG, CN
    WHITMORE, WF
    SCHER, HI
    SOGANI, PC
    MORSE, MJ
    FAIR, WR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (02): : 104 - 105
  • [8] Validation study on the prediction of response to M-VAC neoadjuvant chemotherapy on the basis of expression profiles of 14 predictive genes
    Takata, Ryo
    Katagiri, Toyomasa
    Kanehira, Mitsugu
    Tsunoda, Tatsuhiko
    Shuin, Taro
    Miki, Tsuneharu
    Namiki, Mikio
    Kohri, Kenjiro
    Matsushita, Yasushi
    Fujioka, Tomoaki
    Nakamura, Yusuke
    CANCER RESEARCH, 2006, 66 (08)
  • [9] M-VAC CHEMOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED BLADDER-CANCER
    SKINNER, DG
    JOURNAL OF UROLOGY, 1988, 139 (03): : 570 - 570
  • [10] NEOADJUVANT M-VAC CHEMOTHERAPY IN INVASIVE TRANSITIONAL-CELL CARCINOMA (TCC) OF THE BLADDER - A PILOT-STUDY
    SIMON, SD
    SROUGI, M
    CANCER DRUG DELIVERY, 1986, 3 (01): : 73 - 73
12345